Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Oct;59(4):349–357. doi: 10.1136/jnnp.59.4.349

Cerebrospinal fluid.

E J Thompson 1
PMCID: PMC486067  PMID: 7561910

Full text

PDF
349

Images in this article

349Image
on p.349
351Image
on p.351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L. M., Grønning M. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897–902. doi: 10.1136/jnnp.57.8.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aoyama J., Inaba G., Shimizu T. Third complement component in cerebrospinal fluid in neuro-Behçet's syndrome. Conversion patterns by crossed immunoelectrophoresis. J Neurol Sci. 1979 Apr;41(2):183–190. doi: 10.1016/0022-510x(79)90037-6. [DOI] [PubMed] [Google Scholar]
  3. Baringer J. R., Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol. 1994 Dec;36(6):823–829. doi: 10.1002/ana.410360605. [DOI] [PubMed] [Google Scholar]
  4. Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart-disease after treatment of hypertension. Lancet. 1978 Jan 7;1(8054):1–5. doi: 10.1016/s0140-6736(78)90356-2. [DOI] [PubMed] [Google Scholar]
  5. Bernheimer H., Budka H., Müller P. Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol. 1983;59(2):95–102. doi: 10.1007/BF00691593. [DOI] [PubMed] [Google Scholar]
  6. Cohen S. R., Brooks B. R., Herndon R. M., McKhann G. M. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann Neurol. 1980 Jul;8(1):25–31. doi: 10.1002/ana.410080104. [DOI] [PubMed] [Google Scholar]
  7. Cserr H. F., Knopf P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today. 1992 Dec;13(12):507–512. doi: 10.1016/0167-5699(92)90027-5. [DOI] [PubMed] [Google Scholar]
  8. Dowling P. C., Cook S. D. Disease markers in acute multiple sclerosis. Arch Neurol. 1976 Oct;33(10):668–667. doi: 10.1001/archneur.1976.00500100002003. [DOI] [PubMed] [Google Scholar]
  9. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wochenschr. 1974 Dec 15;52(24):1158–1164. doi: 10.1007/BF01466734. [DOI] [PubMed] [Google Scholar]
  10. Felgenhauer K., Schädlich H. J., Nekic M., Ackermann R. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis? J Neurol Sci. 1985 Dec;71(2-3):291–299. doi: 10.1016/0022-510x(85)90067-x. [DOI] [PubMed] [Google Scholar]
  11. Filippini G., Comi G. C., Cosi V., Bevilacqua L., Ferrarini M., Martinelli V., Bergamaschi R., Filippi M., Citterio A., D'Incerti L. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol. 1994 Jan;241(3):132–137. doi: 10.1007/BF00868339. [DOI] [PubMed] [Google Scholar]
  12. Fredrikson S., Link H., Eneroth P. CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurol Scand. 1987 May;75(5):352–355. doi: 10.1111/j.1600-0404.1987.tb05458.x. [DOI] [PubMed] [Google Scholar]
  13. Hans P., Albert A., Franssen C., Born J. Improved outcome prediction based on CSF extrapolated creatine kinase BB isoenzyme activity and other risk factors in severe head injury. J Neurosurg. 1989 Jul;71(1):54–58. doi: 10.3171/jns.1989.71.1.0054. [DOI] [PubMed] [Google Scholar]
  14. Hughes G. R. The antiphospholipid syndrome: ten years on. Lancet. 1993 Aug 7;342(8867):341–344. doi: 10.1016/0140-6736(93)91477-4. [DOI] [PubMed] [Google Scholar]
  15. Jacobi C., Reiber H., Felgenhauer K. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. J Neurol. 1986 Nov;233(6):358–361. doi: 10.1007/BF00313922. [DOI] [PubMed] [Google Scholar]
  16. Jimi T., Wakayama Y., Shibuya S., Nakata H., Tomaru T., Takahashi Y., Kosaka K., Asano T., Kato K. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta. 1992 Oct 15;211(1-2):37–46. doi: 10.1016/0009-8981(92)90103-w. [DOI] [PubMed] [Google Scholar]
  17. Kamei S., Tetsuka T., Takasu T., Shimizu K. New non-invasive rapid diagnosis of herpes simplex virus encephalitis by quantitative detection of intrathecal antigen with a chemiluminescence assay. J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1112–1114. doi: 10.1136/jnnp.57.9.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keir G., Tasdemir N., Thompson E. J. Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clin Chim Acta. 1993 Jul 16;216(1-2):153–166. doi: 10.1016/0009-8981(93)90148-w. [DOI] [PubMed] [Google Scholar]
  19. Keir G., Zeman A., Brookes G., Porter M., Thompson E. J. Immunoblotting of transferrin in the identification of cerebrospinal fluid otorrhoea and rhinorrhoea. Ann Clin Biochem. 1992 Mar;29(Pt 2):210–213. doi: 10.1177/000456329202900216. [DOI] [PubMed] [Google Scholar]
  20. Kleine T. O., Baerlocher K., Niederer V., Keller H., Reutter F., Tritschler W., Bablok W. Diagnostische Bedeutung der Lactatbestimmung im Liquor bei Meningitis. Dtsch Med Wochenschr. 1979 Apr 13;104(15):553–557. doi: 10.1055/s-0028-1103944. [DOI] [PubMed] [Google Scholar]
  21. Lindquist L., Linné T., Hansson L. O., Kalin M., Axelsson G. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):374–380. doi: 10.1007/BF01962340. [DOI] [PubMed] [Google Scholar]
  22. Lolli F., Siracusa G., Amato M. P., Fratiglioni L., Dal Pozzo G., Galli E., Amaducci L. Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. Acta Neurol Scand. 1991 Apr;83(4):239–243. doi: 10.1111/j.1600-0404.1991.tb04689.x. [DOI] [PubMed] [Google Scholar]
  23. Lowenthal A., Adriaenssens K., Colfs B., Karcher D., Van Heule R. Oligoclonal gammopathy in ataxia-telangiectasia. Z Neurol. 1972;202(1):58–63. doi: 10.1007/BF00316426. [DOI] [PubMed] [Google Scholar]
  24. Luxton R. W., McLean B. N., Thompson E. J. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. Clin Chim Acta. 1990 Mar 15;187(3):297–308. doi: 10.1016/0009-8981(90)90115-9. [DOI] [PubMed] [Google Scholar]
  25. Luxton R. W., Thompson E. J. Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis. J Immunol Methods. 1990 Aug 7;131(2):277–282. doi: 10.1016/0022-1759(90)90199-6. [DOI] [PubMed] [Google Scholar]
  26. Luxton R. W., Thompson E. J. Differential oligoclonal band patterns on polyvinyldifluoride membranes. J Immunol Methods. 1989 Jul 26;121(2):269–274. doi: 10.1016/0022-1759(89)90170-1. [DOI] [PubMed] [Google Scholar]
  27. McLean B. N., Luxton R. W., Thompson E. J. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain. 1990 Oct;113(Pt 5):1269–1289. doi: 10.1093/brain/113.5.1269. [DOI] [PubMed] [Google Scholar]
  28. McLean B. N., Mitchell D. N., Thompson E. J. Local synthesis of specific IgG in the cerebrospinal fluid of patients with neurosarcoidosis detected by antigen immunoblotting using Kveim material. J Neurol Sci. 1990 Nov;99(2-3):165–175. doi: 10.1016/0022-510x(90)90153-e. [DOI] [PubMed] [Google Scholar]
  29. McLean B. N., Rudge P., Thompson E. J. Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):529–531. doi: 10.1136/jnnp.52.4.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McLean B. N., Zeman A. Z., Barnes D., Thompson E. J. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):356–360. doi: 10.1136/jnnp.56.4.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Miller D. H., Ormerod I. E., Rudge P., Kendall B. E., Moseley I. F., McDonald W. I. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol. 1989 Nov;26(5):635–639. doi: 10.1002/ana.410260508. [DOI] [PubMed] [Google Scholar]
  32. Morrissey S. P., Miller D. H., Kendall B. E., Kingsley D. P., Kelly M. A., Francis D. A., MacManus D. G., McDonald W. I. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. 1993 Feb;116(Pt 1):135–146. doi: 10.1093/brain/116.1.135. [DOI] [PubMed] [Google Scholar]
  33. Moseley I. Imaging the adult brain. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):7–21. doi: 10.1136/jnnp.58.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. doi: 10.1093/brain/106.4.809. [DOI] [PubMed] [Google Scholar]
  35. Noordhoek G. T., Kolk A. H., Bjune G., Catty D., Dale J. W., Fine P. E., Godfrey-Faussett P., Cho S. N., Shinnick T., Svenson S. B. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol. 1994 Feb;32(2):277–284. doi: 10.1128/jcm.32.2.277-284.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Paty D. W., Oger J. J., Kastrukoff L. F., Hashimoto S. A., Hooge J. P., Eisen A. A., Eisen K. A., Purves S. J., Low M. D., Brandejs V. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988 Feb;38(2):180–185. doi: 10.1212/wnl.38.2.180. [DOI] [PubMed] [Google Scholar]
  37. Reiber H. External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem. 1995 Feb;41(2):256–263. [PubMed] [Google Scholar]
  38. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991 Jul;37(7):1153–1160. [PubMed] [Google Scholar]
  39. Schaarschmidt H., Prange H. W., Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994 Mar;25(3):558–565. doi: 10.1161/01.str.25.3.558. [DOI] [PubMed] [Google Scholar]
  40. Schädlich H. J., Felgenhauer K. Diagnostic significance of IgG-synthesizing activated B cells in acute inflammatory diseases of the central nervous system. Klin Wochenschr. 1985 Jun 3;63(11):505–510. doi: 10.1007/BF01747980. [DOI] [PubMed] [Google Scholar]
  41. Sindic C. J., Collet-Cassart D., Depré A., Laterre E. C., Masson P. L. C-reactive protein in serum and cerebrospinal fluid in various neurological disorders. Apparent local consumption during bacterial meningitis. J Neurol Sci. 1984 Mar;63(3):339–344. doi: 10.1016/0022-510x(84)90157-6. [DOI] [PubMed] [Google Scholar]
  42. Stendahl-Brodin L., Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1980 Feb;43(2):102–105. doi: 10.1136/jnnp.43.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tyler K. L. Polymerase chain reaction and the diagnosis of viral central nervous system diseases. Ann Neurol. 1994 Dec;36(6):809–811. doi: 10.1002/ana.410360602. [DOI] [PubMed] [Google Scholar]
  44. Vakaet A., Thompson E. J. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry. 1985 Oct;48(10):995–998. doi: 10.1136/jnnp.48.10.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wahlgren N. G., Lindquist C. Haem derivatives in the cerebrospinal fluid after intracranial haemorrhage. Eur Neurol. 1987;26(4):216–221. doi: 10.1159/000116339. [DOI] [PubMed] [Google Scholar]
  46. Walker R. W., Thompson E. J., McDonald W. I. Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features. J Neurol. 1985;232(4):250–259. doi: 10.1007/BF00313789. [DOI] [PubMed] [Google Scholar]
  47. Whitaker J. N., Layton B. A., Herman P. K., Kachelhofer R. D., Burgard S., Bartolucci A. A. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Ann Neurol. 1993 Jan;33(1):10–17. doi: 10.1002/ana.410330104. [DOI] [PubMed] [Google Scholar]
  48. Whitaker J. N., Williams P. H., Layton B. A., McFarland H. F., Stone L. A., Smith M. E., Kachelhofer R. D., Bradley E. L., Burgard S., Zhao G. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis. Ann Neurol. 1994 May;35(5):577–585. doi: 10.1002/ana.410350511. [DOI] [PubMed] [Google Scholar]
  49. Zeman A., McLean B., Keir G., Luxton R., Sharief M., Thompson E. The significance of serum oligoclonal bands in neurological diseases. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):32–35. doi: 10.1136/jnnp.56.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES